1025763-76-1

Basic information

• Product Name: methyl 2-((1-(4-fluorophenyl)-1H-indazol-5-yl)(phenyl)methyl)butanoate
• Synonyms: methyl 2-((1-(4-fluorophenyl)-1H-indazol-5-yl)(phenyl)methyl)butanoate
• CAS NO: 1025763-76-1
• Molecular Weight: 402.468
• Mol File: 1025763-76-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl 2-((1-(4-fluorophenyl)-1H-indazol-5-yl)(phenyl)methyl)butanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-((1-(4-fluorophenyl)-1H-indazol-5-yl)(phenyl)methyl)butanoate(1025763-76-1)
• EPA Substance Registry System: methyl 2-((1-(4-fluorophenyl)-1H-indazol-5-yl)(phenyl)methyl)butanoate(1025763-76-1)

Safety Data

• Hazardous Substances Data: 1025763-76-1(Hazardous Substances Data)

Upstream product

• 1025762-60-0 (1-(4-fluorophenyl)-1H-indazol-5-yl)(phenyl)methanol 
• 82234-60-4 (Z)-1-Methoxy-1-(trimethylsiloxy)buten 
• 55453-12-8 (1-methoxybut-1-enyloxy)trimethylsilane 

Downstream Products

• 1025763-77-2 2-((1-(4-fluorophenyl)-1H-indazol-5-yl)(phenyl)methyl)butanoic acid 

Relevant articles and documents

MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF

Novel non-steroidal compounds are provided which are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including inflammatory and immune diseases, obesity and diabetes having the structure of formula (I), its enantiomers, diastereomers, or a pharmaceutically acceptable salt, or hydrate, thereof, wherein X is (Ia); or X is (Ib); or X is (Ic); (Id) is heterocycle or heteroaryl; E is -N-, -NR1-, -O-, -S-, -SO2- or -CR2-; F is -N-, -NR1a-, -O-, -S-, SO2- or -CR2a-; G is N, -NR1b-, -O-, -S-, SO2- or -CR2b-, provided that the E-F-G containing heterocyclic ring formed does not contain a S-S or S-O bond, and at least one of E, F and G is a heteroatom; J, Ja, M, Ma, Q, Rx, Ry, R1, R1a, R1b, R2, R2a, R2b, and R3 to R21, Z, Za, Zb, and Zc are as defined above.